{"id":"https://openalex.org/W1974472930","doi":"https://doi.org/10.1016/0165-1218(93)90073-m","title":"Decrease in deoxyribonucleotide triphosphate pools and induction of alkaline-labile sites in mouse bone marrow cells by multiple treatments with methotrexate","display_name":"Decrease in deoxyribonucleotide triphosphate pools and induction of alkaline-labile sites in mouse bone marrow cells by multiple treatments with methotrexate","alternate_titles":[],"publication_year":1993,"publication_date":"1993-10-01","ids":{"openalex":"https://openalex.org/W1974472930","doi":"https://doi.org/10.1016/0165-1218(93)90073-m","mag":"1974472930","pmid":"https://pubmed.ncbi.nlm.nih.gov/7692290"},"language":"en","primary_location":{"id":"doi:10.1016/0165-1218(93)90073-m","doi":"https://doi.org/10.1016/0165-1218(93)90073-m","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0165-1218(93)90073-m","pdf_url":null,"source":{"id":"https://openalex.org/S4210195086","display_name":"Mutation Research/Genetic Toxicology","issn_l":"0165-1218","issn":["0165-1218","1878-707X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mutation Research/Genetic Toxicology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1974472930"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108597546","display_name":"Yoshinori Kasahara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Yoshinori Kasahara","raw_affiliation_strings":["Safety Research Department, Teijin Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Research Department, Teijin Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I90469020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111581634","display_name":"Yasuharu Nakai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268147","display_name":"Teijin Pharma Limited (Japan)","ror":"https://ror.org/001144c36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405268147"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuharu Nakai","raw_affiliation_strings":["Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101128017","display_name":"Daishiro Miura","orcid":"https://orcid.org/0009-0009-9605-5623","observed_orcids":["https://orcid.org/0009-0009-9605-5623"]},"institutions":[{"id":"https://openalex.org/I4405268147","display_name":"Teijin Pharma Limited (Japan)","ror":"https://ror.org/001144c36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405268147"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daishiro Miura","raw_affiliation_strings":["Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033421351","display_name":"Hiroshi Kanatani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268147","display_name":"Teijin Pharma Limited (Japan)","ror":"https://ror.org/001144c36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405268147"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroshi Kanatani","raw_affiliation_strings":["Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066993269","display_name":"Kimie Yagi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268147","display_name":"Teijin Pharma Limited (Japan)","ror":"https://ror.org/001144c36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405268147"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kimie Yagi","raw_affiliation_strings":["Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072453175","display_name":"Keiko Hirabayashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268147","display_name":"Teijin Pharma Limited (Japan)","ror":"https://ror.org/001144c36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405268147"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Keiko Hirabayashi","raw_affiliation_strings":["Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083902624","display_name":"Yukimi Takahashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268147","display_name":"Teijin Pharma Limited (Japan)","ror":"https://ror.org/001144c36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405268147"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yukimi Takahashi","raw_affiliation_strings":["Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109011088","display_name":"Yoshihiro Izawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268147","display_name":"Teijin Pharma Limited (Japan)","ror":"https://ror.org/001144c36","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405268147"]},{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshihiro Izawa","raw_affiliation_strings":["Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Research Department, Pharmaceuticals Development Research Laboratories, Teijin Ltd., 4-3-2, Asahigaoka, Hino, Tokyo 191, Japan","institution_ids":["https://openalex.org/I4405268147","https://openalex.org/I90469020"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5108597546"],"corresponding_institution_ids":["https://openalex.org/I90469020"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":12,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"319","issue":"2","first_page":"143","last_page":"149"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10433","display_name":"Carcinogens and Genotoxicity Assessment","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10433","display_name":"Carcinogens and Genotoxicity Assessment","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11359","display_name":"Effects of Radiation Exposure","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":1.0},{"id":"https://openalex.org/keywords/dihydrofolate-reductase-inhibition","display_name":"dihydrofolate reductase inhibition","score":0.9449999928474426},{"id":"https://openalex.org/keywords/micronucleus-induction","display_name":"micronucleus induction","score":0.7979999780654907},{"id":"https://openalex.org/keywords/abasic-sites","display_name":"abasic sites","score":0.9610000252723694},{"id":"https://openalex.org/keywords/bone-marrow-cells","display_name":"bone marrow cells","score":0.8159999847412109},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.609000027179718}],"concepts":[{"id":"https://openalex.org/C45080847","wikidata":"https://www.wikidata.org/wiki/Q1658004","display_name":"Micronucleus test","level":3,"score":0.8304489850997925},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.7968988418579102},{"id":"https://openalex.org/C2780349520","wikidata":"https://www.wikidata.org/wiki/Q28751","display_name":"Deoxyribonucleotide","level":4,"score":0.6727645397186279},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.5693429708480835},{"id":"https://openalex.org/C2781320022","wikidata":"https://www.wikidata.org/wiki/Q417149","display_name":"Dihydrofolate reductase","level":3,"score":0.5680805444717407},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.559011697769165},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5082566142082214},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4131869375705719},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.399507999420166},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28754115104675293},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2820243239402771},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2054278552532196},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.20265161991119385},{"id":"https://openalex.org/C512185932","wikidata":"https://www.wikidata.org/wiki/Q28745","display_name":"Nucleotide","level":3,"score":0.08790108561515808},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001854","descriptor_name":"Bone Marrow Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003854","descriptor_name":"Deoxyribonucleotides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0165-1218(93)90073-m","doi":"https://doi.org/10.1016/0165-1218(93)90073-m","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0165-1218(93)90073-m","pdf_url":null,"source":{"id":"https://openalex.org/S4210195086","display_name":"Mutation Research/Genetic Toxicology","issn_l":"0165-1218","issn":["0165-1218","1878-707X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mutation Research/Genetic Toxicology","raw_type":"journal-article"},{"id":"pmid:7692290","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7692290","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mutation research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W1377731","https://openalex.org/W1496246291","https://openalex.org/W1503561348","https://openalex.org/W1514207813","https://openalex.org/W1542253550","https://openalex.org/W1548178884","https://openalex.org/W1565483916","https://openalex.org/W1586581726","https://openalex.org/W1599809449","https://openalex.org/W1954356438","https://openalex.org/W1965947476","https://openalex.org/W1980405420","https://openalex.org/W1980933651","https://openalex.org/W1984031695","https://openalex.org/W1984986569","https://openalex.org/W1998389261","https://openalex.org/W2004911118","https://openalex.org/W2007091552","https://openalex.org/W2016306782","https://openalex.org/W2019026020","https://openalex.org/W2046380747","https://openalex.org/W2056503954","https://openalex.org/W2057512249","https://openalex.org/W2059946255","https://openalex.org/W2062101978","https://openalex.org/W2073602724","https://openalex.org/W2076999723","https://openalex.org/W2077008254","https://openalex.org/W2085729093","https://openalex.org/W2086752273","https://openalex.org/W2104184168","https://openalex.org/W2130386700","https://openalex.org/W2156744483","https://openalex.org/W2166152547","https://openalex.org/W2310873296","https://openalex.org/W2339862575","https://openalex.org/W2413855324","https://openalex.org/W4234736483"],"related_works":["https://openalex.org/W2073602724","https://openalex.org/W2339862575","https://openalex.org/W2621417961","https://openalex.org/W1561752316","https://openalex.org/W2090686311","https://openalex.org/W2128303373","https://openalex.org/W1983255493","https://openalex.org/W1918503526","https://openalex.org/W2004911118","https://openalex.org/W2102350488"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1974472930","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
